BRAXIA SCIENTIFIC CORP. Market Cap ($566.56K)
Market Cap & Net Worth: BRAXIA SCIENTIFIC CORP. (4960)
BRAXIA SCIENTIFIC CORP. market cap. BRAXIA SCIENTIFIC CORP. (F:4960) has a market capitalization of $566.56K (€484.61K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31019 globally and #2726 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BRAXIA SCIENTIFIC CORP.'s stock price €0.00 by its total outstanding shares 283280350 (283.28 Million). Also see BRAXIA SCIENTIFIC CORP. (4960) cash conversion ratio for how efficiently the company converts equity into cash flow.
BRAXIA SCIENTIFIC CORP. Market Cap History (2020–2026)
BRAXIA SCIENTIFIC CORP. market cap history from 2020 to 2026. Data shows change from $192.09 Million to $662.37K (-52.45% CAGR). Check 4960 share price today for real-time trading data and today's change.
BRAXIA SCIENTIFIC CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BRAXIA SCIENTIFIC CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore BRAXIA SCIENTIFIC CORP. net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.85x
BRAXIA SCIENTIFIC CORP.'s market cap is 1.85 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $17.22 Million | $1.01 Million | -$88.83 Million | 17.08x | N/A |
| 2022 | $6.76 Million | $1.49 Million | -$12.13 Million | 4.54x | N/A |
| 2023 | $3.48 Million | $1.88 Million | -$13.14 Million | 1.85x | N/A |
Competitor Companies of 4960 by Market Capitalization
Companies near BRAXIA SCIENTIFIC CORP. in the global market cap rankings as of November 3, 2026. Also see total assets of BRAXIA SCIENTIFIC CORP. for a full breakdown of the balance sheet.
Key companies related to BRAXIA SCIENTIFIC CORP. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of BRAXIA SCIENTIFIC CORP. (2020–2026)
Market capitalization of BRAXIA SCIENTIFIC CORP. from 2020 to today. Between 2020 and today, BRAXIA SCIENTIFIC CORP.'s market cap moved from $192.09 Million to $ 662.37K, with a yearly change of -52.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €662.37K | 0.00% |
| 2025 | €662.37K | 0.00% |
| 2024 | €662.37K | -80.95% |
| 2023 | €3.48 Million | -48.53% |
| 2022 | €6.76 Million | -60.77% |
| 2021 | €17.22 Million | -91.03% |
| 2020 | €192.09 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of BRAXIA SCIENTIFIC CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $566.56K USD |
| MoneyControl | $566.56K USD |
| MarketWatch | $566.56K USD |
| marketcap.company | $566.56K USD |
| Reuters | $566.56K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BRAXIA SCIENTIFIC CORP.
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery metho… Read more